For example, the PI3K/Akt-mTOR pathway, which is typically altered in cancers—including OS—, upregulates cellular glucose uptake, while oncogenes c-MYC and hypoxia-inducible factor-1 (HIF-1) upregulate glycolytic enzymes [59, 70–72]. The gene discussed is MTOR; the disease is cancer.